Category Archives: Cardiovascular
New York, NY (August 02, 2023) The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) in its List of Essential Medicines. The medication, known as a “polypill,” includes three active ingredients (acetylsalicylic acid, ramipril, and atorvastatin) and […]
Aug
Abstract Resting heart rate is associated with cardiovascular diseases and mortality in observational and Mendelian randomization studies. The aims of this study are to extend the number of resting heart rate associated genetic variants and to obtain further insights in resting heart rate biology and its clinical consequences. A genome-wide meta-analysis of 100 studies in […]
Aug
AI dominated new technology discussions “We have a big focus on the rise of artificial intelligence (AI) and machine learning, and I think that has been a core part of this year’s meeting,” Nicol told Cardiovascular Business. “I think it is becoming more real for people because we are not just hearing about it more […]
Aug
On December 27, 2016, Carrie Fisher of Star Wars fame, died at the age of 60, four days after suffering a massive heart attack. Her mother, Debbie Reynolds, who had expected her at Christmas dinner, died the following day. Johnny and June Cash died within four months of each other. When June died of complications […]
Aug
Hims wants to have a heart-to-heart with customers. What’s happening: Hims & Hers, a digital health and wellness company, launched Heart Health by Hims, a dual-action program coupling erectile dysfunction treatment and cardiovascular preventative care. What it is: Through a partnership with Labcorp, providers on the platform will be able to screen Heart Health by […]
Aug
The VICTORION-2-PREVENT trial is taking place at the Gordon and Leslie Diamond Health Care Centre at the University of British Columbia and is currently in the recruiting process. The trial’s main objective is to provide evidence in favor of using inclisiran to lower cardiovascular risk in individuals who already have atherosclerotic cardiovascular disease (ASCVD) and […]
Aug
Ryan Haumschild, PharmD, MS, MBA: Let’s talk through the importance of the management of the adverse effects for SERDs [selective estrogen receptor degraders] and even the managed care decisions that come along with adverse effect management and real coverage criteria for these different treatments. It’s important that we continue to develop a plan to monitor […]
Aug
Exploring the Role of Cutting-Edge Atherectomy Devices Technology in Improving Cardiovascular Health Cardiovascular health is a critical aspect of overall well-being, and advancements in medical technology are continually improving the ways in which we can maintain and improve heart health. One such advancement is the development of cutting-edge atherectomy devices technology, which is revolutionizing the […]
Cardiovascular
Montefiore St. Luke’s Cornwall opens new Cardiovascular Medicine & Interventional Radiology Lab as part of major expansion funded by the Kaplan Family
Aug
NEWBURGH- Montefiore St. Luke’s Cornwall (MSLC) is pleased to announce the completion of the newly renovated Kaplan Family Center for Cardiovascular Medicine and Interventional Radiology located on the hospital’s Newburgh campus. Through the generosity of a $4 million grant from the Kaplan Family, MSLC expanded its Cardiovascular Medicine and Interventional Radiology (CVIR) Program to include the […]